BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21127457)

  • 1. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
    Lobmeyer MT; Wang L; Zineh I; Turner ST; Gums JG; Chapman AB; Cooper-DeHoff RM; Beitelshees AL; Bailey KR; Boerwinkle E; Pepine CJ; Johnson JA
    Pharmacogenet Genomics; 2011 Jan; 21(1):42-9. PubMed ID: 21127457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
    Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
    Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
    Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans.
    Cohn HI; Xi Y; Pesant S; Harris DM; Hyslop T; Falkner B; Eckhart AD
    Hypertension; 2009 Jul; 54(1):71-6. PubMed ID: 19487588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
    McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
    Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.
    Kurnik D; Cunningham AJ; Sofowora GG; Kohli U; Li C; Friedman EA; Muszkat M; Menon UB; Wood AJ; Stein CM
    Pharmacogenomics; 2009 Oct; 10(10):1581-7. PubMed ID: 19842931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
    McDonough CW; Warren HR; Jack JR; Motsinger-Reif AA; Armstrong ND; Bis JC; House JS; Singh S; El Rouby NM; Gong Y; Mychaleckyj JC; Rotroff DM; Benavente OR; Caulfield MJ; Doria A; Pepine CJ; Psaty BM; Glorioso V; Glorioso N; Hiltunen TP; Kontula KK; Arnett DK; Buse JB; Irvin MR; Johnson JA; Munroe PB; Wagner MJ; Cooper-DeHoff RM
    Clin Pharmacol Ther; 2021 Sep; 110(3):723-732. PubMed ID: 34231218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
    Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA
    Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
    Shahin MH; Sá AC; Webb A; Gong Y; Langaee T; McDonough CW; Riva A; Beitleshees AL; Chapman AB; Gums JG; Turner ST; Boerwinkle E; Scherer SE; Sadee W; Cooper-DeHoff RM; Johnson JA
    Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28115488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
    Gong Y; McDonough CW; Beitelshees AL; El Rouby N; Hiltunen TP; O'Connell JR; Padmanabhan S; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Donner KM; Kontula KK; Bailey KR; Boerwinkle E; Takahashi A; Tanaka T; Kubo M; Chapman AB; Turner ST; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Hypertens; 2015 Nov; 33(11):2278-85. PubMed ID: 26425837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.
    Liggett SB; Cresci S; Kelly RJ; Syed FM; Matkovich SJ; Hahn HS; Diwan A; Martini JS; Sparks L; Parekh RR; Spertus JA; Koch WJ; Kardia SL; Dorn GW
    Nat Med; 2008 May; 14(5):510-7. PubMed ID: 18425130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
    Niu Y; Gong Y; Langaee TY; Davis HM; Elewa H; Beitelshees AL; Moss JI; Cooper-Dehoff RM; Pepine CJ; Johnson JA
    Circ Cardiovasc Genet; 2010 Dec; 3(6):548-55. PubMed ID: 21156931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Polymorphisms of ADRBK1 Gene and Plasma Renin Activity in Hypertensive Patients: A Case-Control Study.
    Li Y; Li N; Yao X; Heizati M; Zhang D; Zhu Q; Chang G; Zhang X
    Med Sci Monit; 2016 Aug; 22():2981-8. PubMed ID: 27555048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
    Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Categorical complexities of Plasmodium falciparum malaria in individuals is associated with genetic variations in ADORA2A and GRK5 genes.
    Gupta H; Jain A; Saadi AV; Vasudevan TG; Hande MH; D'Souza SC; Ghosh SK; Umakanth S; Satyamoorthy K
    Infect Genet Evol; 2015 Aug; 34():188-99. PubMed ID: 26066465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between gene polymorphism of GRK5 and breast cancer risk in Chinese population.
    Wu B; Xing T; Li H; He W; Li B
    J BUON; 2021; 26(3):741-746. PubMed ID: 34268929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
    Turner ST; Boerwinkle E; O'Connell JR; Bailey KR; Gong Y; Chapman AB; McDonough CW; Beitelshees AL; Schwartz GL; Gums JG; Padmanabhan S; Hiltunen TP; Citterio L; Donner KM; Hedner T; Lanzani C; Melander O; Saarela J; Ripatti S; Wahlstrand B; Manunta P; Kontula K; Dominiczak AF; Cooper-DeHoff RM; Johnson JA
    Hypertension; 2013 Aug; 62(2):391-7. PubMed ID: 23753411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
    Price ET; Pacanowski MA; Martin MA; Cooper-DeHoff RM; Pepine CJ; Zineh I; Johnson JA
    Pharmacogenet Genomics; 2011 Jun; 21(6):333-40. PubMed ID: 21562465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.